Zimmer Biomet Gets FDA Clearance for Persona Revision Knee System

By MedTech Intelligence Staff

A U.S. launch of the product is expected in just a few weeks.

This week Zimmer Biomet Holdings, Inc. announced 510(k) clearance of its Persona Revision Knee System for a more customized approach to knee replacements. The product has anatomic components that are intended to match a patient’s anatomy, along with instruments that give surgeons more flexibility during the procedure. The company expects to launch the product in the United States in just a few weeks.

“The highly-anticipated release of Persona Revision provides surgeons with a full portfolio for the continuum of knee arthroplasty care and the ability to truly tailor an implant solution based on each patient’s unique requirements,” said Ivan Tornos, group president of global orthopedics at Zimmer Biomet in a company press release.

The revision system features the company’s trabecular metal technology, which is a highly porous biomaterial that mimics the structure, function and physiological properties of bone. It also has a bearing surface with actively stabilized Vitamin E, which helps prevent oxidation and provides wear resistance and strength to the implant.

Related Articles

About The Author

MedTech Intelligence